NCT04604171 is a NA clinical trial of Action Observation Training in Stroke Sequelae, sponsored by Azienda USL Toscana Sud Est.

Who is sponsoring NCT04604171?

NCT04604171 is sponsored by Azienda USL Toscana Sud Est.

What drugs are being tested in NCT04604171?

Interventions in NCT04604171: Action Observation Training, Task Oriented Training, Conventional Treatment.

What condition does NCT04604171 study?

NCT04604171 studies Stroke Sequelae.

Is NCT04604171 still recruiting?

NCT04604171 is currently completed. Last updated 27 October 2020.

Last reviewed 2020-10-27 · How we verify

NCT04604171

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Action Observation Training for Upper Limb Recovery in Patients With Stroke

Completed NA Last updated 27 October 2020

What this trial tests

NA trial testing Action Observation Training in Stroke Sequelae in 32 participants. Completed in 31 July 2020.

Timeline

1 May 2020

Primary endpoint
30 June 2020

31 July 2020

Quick facts

Lead sponsor	Azienda USL Toscana Sud Est
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	32
Start date	1 May 2020
Primary completion	30 June 2020
Estimated completion	31 July 2020
Sites	1 location across Italy

Drugs / interventions tested

Action Observation Training
Task Oriented Training
Conventional Treatment — full drug profile →

Conditions studied

Stroke Sequelae — all drugs for Stroke Sequelae →

Sponsor

Azienda USL Toscana Sud Est

Who can join

Adults 18 to 90, any sex, with Stroke Sequelae. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background: Due to the complexity of the interventions in recovering the upper limb, at the moment there is a lack of evidence about the efficacy of rehabilitative interventions. Action Observation Training (AOT) constitutes a promising rehabilitative method to improve upper limb motor recovery in stroke patients. Objective: The aim of the present study was to evaluate the effect of AOT both on upper limb recovery and on functional outcome when compared to patients treated with the task oriented training (TOT). Both treatments were added to traditional rehabilitative treatment.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Action observation for upper limb rehabilitation after stroke.
Borges LR, Fernandes AB, Oliveira Dos Passos J, Rego IAO, et al · · 2022 · cited 22× · PMID 35930301 · DOI 10.1002/14651858.cd011887.pub3
Action Observation Therapy for Upper Limb Recovery in Patients with Stroke: A Randomized Controlled Pilot Study.
Mancuso M, Tondo SD, Costantini E, Damora A, et al · · 2021 · cited 19× · PMID 33652680 · DOI 10.3390/brainsci11030290

Verify or expand the search:

Other trials of Action Observation Training

Trials testing the same drug.

NCT06459375 — Effects of Modified Otago Versus Action Observation on Strength, Mobility and Fall Risk in Diabetic Neuropathy · NA · completed
NCT06268223 — Home-Based Action Observation Training for Chewing and Swallowing Function · NA · completed

Other recruiting trials for Stroke Sequelae

Currently open trials in the same condition.

NCT07113067 — Accelerated rTMS vs. Sham for Stroke Apathy · Phase 1, PHASE2 · recruiting
NCT06797154 — A Novel Wrist Wearable Sensor System to Promote Hemiparetic Upper Extremity Use in Subacute Stroke Survivors · NA · recruiting
NCT05626894 — Novel Wrist Sensor System to Promote Hemiparetic Arm Use in Home Daily Life of Chronic Stroke Survivors · Phase 2 · recruiting
NCT06289569 — Home Tele Rehabilitation Therapy for Vascular Dementia · NA · recruiting
NCT06593184 — Efficacy of Trans-spinal Magnetic Stimulation on Functional Mobility in Chronic Stroke Patients · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04604171 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Azienda USL Toscana Sud Est
Last refreshed: 27 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04604171.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing